Literature DB >> 15023336

Endostatin's antiangiogenic signaling network.

Amir Abdollahi1, Philip Hahnfeldt, Christian Maercker, Hermann-Josef Gröne, Juergen Debus, Wilhelm Ansorge, Judah Folkman, Lynn Hlatky, Peter E Huber.   

Abstract

It is here demonstrated that the set of gene expressions underlying the angiogenic balance in tissues can be molecularly reset en masse by a single protein. Using genome-wide expression profiling, coupled with RT-PCR and phosphorylation analysis, we show that the endogenous angiogenesis inhibitor endostatin downregulates many signaling pathways in human microvascular endothelium associated with proangiogenic activity. Simultaneously, endostatin is found to upregulate many antiangiogenic genes. The result is a unique alignment between the direction of gene regulation and angiogenic status. Profiling further reveals the regulation of genes not heretofore associated with angiogenesis. Our analysis of coregulated genes shows complex interpathway communications in an intricate signaling network that both recapitulates and extends on current understanding of the angiogenic process. More generally, insights into the nature of genetic networking from the cell biologic and therapeutic perspectives are revealed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023336     DOI: 10.1016/s1097-2765(04)00102-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  98 in total

1.  Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.

Authors:  Yitao Jia; Min Liu; Wangang Huang; Zhenbao Wang; Yutong He; Jianhua Wu; Shuguang Ren; Yingchao Ju; Ruichao Geng; Zhongxin Li
Journal:  Pathol Oncol Res       Date:  2011-09-22       Impact factor: 3.201

2.  Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells.

Authors:  Chiara M Mazzanti; Anita Tandle; Dominique Lorang; Nick Costouros; David Roberts; Generoso Bevilacqua; Steven K Libutti
Journal:  Genome Res       Date:  2004-08       Impact factor: 9.043

3.  Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.

Authors:  Olcay Tatar; Kei Shinoda; Annemarie Adam; Tillmann Eckert; Claus Eckardt; Klaus Lucke; Christoph Deuter; Karl Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

4.  Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma.

Authors:  You-Hua Wu; Jian-Guo Cao; Hong-Lin Xiang; Hong Xia; Yong Qin; A-Ji Huang; Di Xiao; Fang Xu
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

5.  Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Koichi Uno; Carol Merges; Lei Zhang; D Scott McLeod; Gerard A Lutty
Journal:  Arch Ophthalmol       Date:  2008-05

6.  A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.

Authors:  Ling Zhang; Xi Shen; Qing Lu; Qingwei Zhou; Jiaqi Gu; Renbao Gan; Hui Zhang; Xiaodong Sun; Bing Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

7.  Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation.

Authors:  Neel R Sodha; Richard T Clements; Munir Boodhwani; Shu-Hua Xu; Roger J Laham; Cesario Bianchi; Frank W Sellke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-12       Impact factor: 4.733

8.  Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer.

Authors:  José Augusto Rinck-Junior; Cristiane Oliveira; Gustavo Jacob Lourenço; Regina Aparecida Martinho Sagarra; Sophie Françoise Mauricette Derchain; José Getulio Segalla; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-05       Impact factor: 4.553

Review 9.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

Review 10.  Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.

Authors:  Gavin Thurston; Nicholas W Gale
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.